Navigation Links
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction
Date:7/14/2014

ether as a result of new information, future events and developments or otherwise, except as required by law.

Important Information for Investors and Shareholders

This communication does not constitute an offer to sell or the solicitation of an offer to buy any securities or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. In connection with the proposed transaction between Mallinckrodt and Questcor, Mallinckrodt has filed with the Securities and Exchange Commission (the "SEC") a registration statement on Form S-4 containing a joint proxy statement of Mallinckrodt and Questcor that also constitutes a prospectus of Mallinckrodt. The registration statement on Form S-4 was declared effective by the SEC on July 11, 2014. Each of Mallinckrodt and Questcor will commence mailing the joint proxy statement/prospectus to its respective shareholders as soon as possible. INVESTORS AND SECURITY HOLDERS OF MALLINCKRODT AND QUESTCOR ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND OTHER DOCUMENTS THAT HAVE BEEN OR WILL BE FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and security holders can obtain free copies of the joint proxy statement/prospectus, the registration statement and other documents filed with the SEC by Mallinckrodt and Questcor through the website maintained by the SEC at http://www.sec.gov.  

Participants in the Merger Solicitation

Mallinckrodt, Questcor, their respective directors and certain of their executive officers and employees may be considered participants in the solicitation of proxies in connection with the proposed transaction.  Information regarding the persons who may, u
'/>"/>

SOURCE Mallinckrodt plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
2. Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
3. Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application
4. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
5. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
6. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
7. Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
8. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
9. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
10. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aegerion Pharmaceuticals, Inc.
11. Crealta Pharmaceuticals LLC Announces Completion of the Acquisition of Substantially All of the Assets of Savient Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... BEIJING , Oct. 30, 2014 China ... "Company"), a leading fully integrated plasma-based biopharmaceutical company in ... Company plans to release third quarter 2014 financial results ... The Company,s management will hold a ... November 6, 2014, which is 8:30 p.m., Beijing Time ...
(Date:10/30/2014)...  CytRx Corporation (NASDAQ: CYTR ), ... oncology, today announced an upcoming presentation highlighting its ... The presentation, titled, "Drug Conjugates Bind Covalently to ... Sant P. Chawla , M.D., F.R.A.C.P., Director ... of the Company,s ongoing global, pivotal Phase 3 ...
(Date:10/30/2014)... 2014 Extensiv hydrolysierte ... von Kuhmilchverträglichkeit     Kuhmilchproteinallergie (KMPA) ist ... und Kleinkindern. Der bisher übliche Umgang mit ... Babys bzw. deren stillenden Mütter Milchproteine zu ... bei einer beträchtlichen Anzahl von Kindern der ...
Breaking Medicine Technology:China Biologic to Report Third Quarter 2014 Financial Results 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 2CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 3CytRx Announces Oral Presentation at 2014 Chemotherapy Foundation Symposium 4Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 2Experten präsentieren neuste Forschungsergebnisse auf dem Allergy Day 3
... -- Concord Medical Services Holdings Limited ("Concord Medical" ... of the largest network of radiotherapy and diagnostic imaging centers ... the third quarter ended September 30, 2011. ... were RMB124.7 million ($19.6 million)(A) in the third quarter 2011, ...
... -- Nephros, Inc. (OTC Bulletin Board: NEPH ) ... 30, 2011. Recent Highlights ... to be exercised; Received initial review questions from FDA ... Financial Performance for the Third ...
Cached Medicine Technology:Concord Medical Reports Third Quarter 2011 Financial Results 2Concord Medical Reports Third Quarter 2011 Financial Results 3Concord Medical Reports Third Quarter 2011 Financial Results 4Concord Medical Reports Third Quarter 2011 Financial Results 5Concord Medical Reports Third Quarter 2011 Financial Results 6Concord Medical Reports Third Quarter 2011 Financial Results 7Concord Medical Reports Third Quarter 2011 Financial Results 8Concord Medical Reports Third Quarter 2011 Financial Results 9Concord Medical Reports Third Quarter 2011 Financial Results 10Concord Medical Reports Third Quarter 2011 Financial Results 11Concord Medical Reports Third Quarter 2011 Financial Results 12Concord Medical Reports Third Quarter 2011 Financial Results 13Concord Medical Reports Third Quarter 2011 Financial Results 14Concord Medical Reports Third Quarter 2011 Financial Results 15Nephros Reports Third Quarter 2011 Financial Results 2Nephros Reports Third Quarter 2011 Financial Results 3Nephros Reports Third Quarter 2011 Financial Results 4Nephros Reports Third Quarter 2011 Financial Results 5
(Date:10/30/2014)... HealthDay Reporter , WEDNESDAY, Oct. 29, ... been identified that appear linked to autism spectrum disorders, ... are on their way to discovering up to 1,000 ... Autism spectrum disorders include a range of developmental disabilities ... An estimated one in 68 U.S. children has an ...
(Date:10/30/2014)... 30, 2014 Horse Sense & ... riding to special needs individuals in the Jacksonville area, ... November 15 from 10-2:00 p.m. at Bailey's Farm (2202 ... to the public and is designed to raise awareness ... to the HSS Round-Up is free. Ticket purchases will ...
(Date:10/30/2014)... 30, 2014 The human brain is ... vigorously exercised to help maintain better mental health, according ... ‘Dementia Express: Lose Your Memory in 100 Ways’ for ... and sometimes conflicting attitudes to help keep the reader ... a reader must decipher the hidden logic within. , ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- When it comes to heart ... men to delay care when they have symptoms that spell ... to the hospital with a more severe or advanced stage ... study author Catherine Kreatsoulas, a Fulbright Scholar and research fellow ... news release from the Heart and Stroke Foundation of Canada. ...
(Date:10/30/2014)... Many U.S. colleges have indoor tanning salons on ... risk for skin cancer, researchers report. Tanning ... so colleges should adopt tanning-free policies, to help ... health efforts are needed to raise university administration ... indoor tanning poses to young adults in order ...
Breaking Medicine News(10 mins):Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 2Health News:Discovery of 100-Plus Genes Tied to Autism May Improve Treatments 3Health News:Horse Sense & Sensitivity, Jacksonville Non-profit, To Hold 2nd Annual Round-Up 2Health News:‘Dementia Express’ Offers Contradictory and Sometimes Reverse Thinking, All to Keep its Reader on Their Toes With an Active Mind. 2Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Many U.S. Colleges Have Indoor Tanning Salons On, Near Campus: Study 2
... Alcohol Support Team Board of Directors and Commits all ... Corporate Charity Work to Benefit FASTeam, ... a year, more than Spina Bifida, Down Syndrome and Muscular,Dystrophy ... an,increase in efforts to promote prevention of prenatal alcohol exposure ...
... LAKE FOREST, Ill., July 7 Hospira, Inc.,(NYSE: ... today announced that it will host a conference call ... 2008, at 8 a.m. Central,time., The company will ... stock market open and the conference call., A ...
... 100%, ARLINGTON HEIGHTS, Ill., July 7 ... are satisfied with,their decision, have low complication rates ... study in July,s Plastic and Reconstructive Surgery(R), the,official ... Surgeons,(ASPS). In addition, breast reconstruction after preventive mastectomy ...
... 2 should be tested for high cholesterol, group says , , ... to the impact of the childhood obesity epidemic in the ... kids as young as 8 years old be given cholesterol-lowering ... , The American Academy of Pediatrics also recommends that children ...
... AIDS Fundraising Event Goes GREEN with Online ... Communications, Recycling and Awareness, SAN FRANCISCO, July ... Francisco announced today key initiatives to ,Green, the,HIV fundraising event ... introduction of Green Walkers, composting, and,enhanced recycling., "With the ...
... MEETING, Pa., July 7 /Xinhua-PRNewswire/ -- BMP ... ,Company,) today,announced that it received the New ... enterprise with foreign investment in the People,s,Republic ... Industry and,Commerce (SHAIC). With receipt of this ...
Cached Medicine News:Health News:K Squared Sponsors F.A.S.T. Ride 150-mile Motorcycle Tour August 17 2Health News:98% of Elective Mastectomy Patients Would Have Reconstruction Again, Says ASPS Study 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 2Health News:Pediatricians Recommend Cholesterol Drugs for Some Kids 3Health News:AIDS Walk San Francisco Takes Big Green Step Forward 2Health News:AIDS Walk San Francisco Takes Big Green Step Forward 3Health News:BMP Sunstone Completes Acquisition of Shanghai Rongheng Pharmaceutical Co., Ltd 2
Pediatric model. Blades: 10 mm. Solid blades with locking mechanism. Dull finish....
Solid 16 mm blades. Self-locking mechanism. Dull finish....
Fenestrated 16 mm blades. Self-locking mechanism. Dull finish....
... The Kawesch-Lancaster Lasik speculum ... one curved to provide clearance ... solid blades retract the lids ... path for the microkeratome. The ...
Medicine Products: